RPG Life Sciences Limited
RPG Life Sciences Ltd is engaged in the manufacturing and marketing of Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs) in the domestic and international market.The company is a part of RPG group which is a diversified conglomerate with interests in areas of infrastructure, tyres, information technology, pharmaceuticals, energy and plantations.The group is headed by Harsh Goenka.
What RPG files
- Others64
- Updates30
- Important25
- Investor Meet25
- Board Meeting15
- PPTs10
RPG Life Sciences has allotted a 40% equity stake in its wholly owned subsidiary, RPG Active Pharma, to investors for INR 243.33 Cr. RPG Active Pharma remains a subsidiary post-investment, unlocking value and driving growth in its active pharmaceutical business segment.
RPG Life Sciences provided an update regarding its Analyst/Institutional Call. Details from the call, which took place on September 3, 2026, are now available on the company's website.
RPG Lifesciences Limited will host an analyst/institutional investor meeting to provide an API business update on Thursday, September 03, 2026, at 4:00 PM IST.
RPG Life Sciences has strategically spun off its Active Pharmaceutical Ingredients (API) business into a new subsidiary, RPG Active Pharma (RPGAP). This move aims for sharper focus and growth. The API unit recorded ~95.1 Cr in external sales in FY26, specializing in high-value niche products. In a key development, RPGAP...
RPG Life Sciences Limited will host a virtual investors/analysts group call on Thursday, September 3, 2026, at 04:00 PM IST. The call will discuss the Company's recent strategic announcement. Dial-in details and the investor presentation will be shared separately.